PrabhuNKZhuAMezaJM, et al.Transition to ductal stenting for single ventricle patients led to improved survival: an institutional case series. World J Pediatr Congenit Heart Surg. 2021;12(4):518–526.
2.
PetrucciOO’BrienSMJacobsMLJacobsJPManningPBEghtesadyP. Risk factors for mortality and morbidity after the neonatal Blalock-Taussig shunt procedure. Ann Thorac Surg. 2011;92(2):642–651.
3.
AlsoufiBGillespieSMoriMClabbyMKanterKKogonB. Factors affecting death and progression towards next stage following modified Blalock-Taussig shunt in neonates. Eur J Cardiothorac Surg. 2016;50(1):169–177.
4.
AlsoufiBGillespieSKogonB, et al.Results of palliation with an initial modified Blalock-Taussig shunt in neonates with single ventricle anomalies associated with restrictive pulmonary blood flow. Ann Thorac Surg. 2015;99(5):1639–1646.
5.
AlsoufiBMcCrackenCKochilasLKClabbyMKanterK. Factors associated with interstage mortality following neonatal single ventricle palliation. World J Pediatr Congenit Heart Surg. 2018;9(6):616–623.
6.
BenthamJRZavaNKHarrisonWJ, et al.Duct stenting versus modified Blalock-Taussig shunt in neonates with duct-dependent pulmonary blood flow: associations with clinical outcomes in a multicenter national study. Circulation. 2018;137(6):581–588.
7.
GlatzACPetitCJGoldsteinBH, et al.Comparison between patent ductus arteriosus stent and modified Blalock-Taussig shunt as palliation for infants with ductal-dependent pulmonary blood flow: insights from the congenital catheterization research collaborative. Circulation. 2018;137(6):589–601.
8.
BoucekDMQureshiAMGoldsteinBHPetitCJGlatzAC. Blalock-Taussig shunt versus patent ductus arteriosus stent as first palliation for ductal-dependent pulmonary circulation lesions: a review of the literature. Congenit Heart Dis. 2019;14(1):105–109.
9.
SantoroGPalladinoMTCapozziGIaconoCRussoMGCalabròR. Pulmonary artery growth following arterial duct stenting in congenital heart disease with duct-dependent pulmonary circulation. Catheter Cardiovasc Interv. 2009;74(7):1072–1076.
